BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Clinical Outcome
5 results:

  • 1. Early lymphocyte collection for anti-CD19 carT production improves T-cell fitness in patients with relapsed/refractory diffuse large B-cell lymphoma.
    Dubnikov Sharon T; Assayag M; Avni B; Kfir-Erenfeld S; Lebel E; Gatt ME; Goldschmidt N; Stepensky P; Asherie N; Grisariu S
    Br J Haematol; 2023 Jul; 202(1):74-85. PubMed ID: 37070396
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deleting DNMT3A in car T cells prevents exhaustion and enhances antitumor activity.
    Prinzing B; Zebley CC; Petersen CT; Fan Y; Anido AA; Yi Z; Nguyen P; Houke H; Bell M; Haydar D; Brown C; Boi SK; Alli S; Crawford JC; Riberdy JM; Park JJ; Zhou S; Velasquez MP; DeRenzo C; Lazzarotto CR; Tsai SQ; Vogel P; Pruett-Miller SM; Langfitt DM; Gottschalk S; Youngblood B; Krenciute G
    Sci Transl Med; 2021 Nov; 13(620):eabh0272. PubMed ID: 34788079
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
    Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
    Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anti-CD19 car T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
    Garfall AL; Stadtmauer EA; Hwang WT; Lacey SF; Melenhorst JJ; Krevvata M; Carroll MP; Matsui WH; Wang Q; Dhodapkar MV; Dhodapkar K; Das R; Vogl DT; Weiss BM; Cohen AD; Mangan PA; Ayers EC; Nunez-Cruz S; Kulikovskaya I; Davis MM; Lamontagne A; Dengel K; Kerr ND; Young RM; Siegel DL; Levine BL; Milone MC; Maus MV; June CH
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669947
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
    Louis CU; Savoldo B; Dotti G; Pule M; Yvon E; Myers GD; Rossig C; Russell HV; Diouf O; Liu E; Liu H; Wu MF; Gee AP; Mei Z; Rooney CM; Heslop HE; Brenner MK
    Blood; 2011 Dec; 118(23):6050-6. PubMed ID: 21984804
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.